<DOC>
	<DOC>NCT00377806</DOC>
	<brief_summary>This study will assess the efficacy, safety and tolerability of topically administered diclofenac gel versus placebo with respect to the symptom score (pain, temperature and size of erythema along the superficial vein)</brief_summary>
	<brief_title>Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins</brief_title>
	<detailed_description />
	<mesh_term>Thrombophlebitis</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Patients with indication of topical treatment for inflammatory, painful superficial thrombophlebitis of the upper limb Spontaneous or iatrogenic superficial thrombophebitis of the upper limb Hypersensitivity to the study drug, to actylsalicyclic acid and other nonsteroidal antirheumatic agents and to the ingredients of the gel Paitents who had developed asthma, skin reactions or acute rhinitis to acetylsalicylic acid or other nonsteroidal antirheumatic agents in the past Therapy with varicose vein remedies, antithrombotic or antiphlogistic agents as well as corticosteroids for more than 7 days prior to study start Acute deep vein thrombosis and thrombophlebitis extending into other deep veins Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs</keyword>
</DOC>